Find therapies in clinical trials near you – page 21

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments

A study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer

A study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Zanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults

Zanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults

Early Stopping of Antibiotic Treatment in Children with Cancer and Febrile Neutropenia

Early Stopping of Antibiotic Treatment in Children with Cancer and Febrile Neutropenia

Long-Term Study of Imeroprubart in Adults With Graves' Disease

Long-Term Study of Imeroprubart in Adults With Graves' Disease

Long-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials

Long-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

Mesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission

Mesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission